Morocco will soon proceed to manufacture and syringe anti-Covid-19 vaccines made in Morocco. The first doses of the precious product, the result of collaboration between the Chinese laboratory Sinopharm, which produced the vaccine of the same name, and its Moroccan counterpart Sothema, are announced for next December.
This step has been expected since August 2020, the date of the signing of a partnership agreement with China for the production in Morocco of vaccines and biological therapy drugs, as well as other serums, reports Al Ahdath Al Maghribia, adding that as part of the partnership between the laboratories of the two countries, a delegation of Chinese experts is expected in the second half of November in the facilities of Sothema, the vaccine production space, for an evaluation of the equipment and the organization of the reception of the raw materials to be used.
Sothema Laboratories have a production capacity of 5 million doses per month at the moment, with the possibility of greater capacity in the years to come.
